SEC Form 4 · accession 0001209191-17-039208
bluebird bio, Inc. · BLUE
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Mark Vachon
Director
Period of report
Jun 8, 2017
Accepted (ET)
Jun 12, 2017 · 5:00 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001293971
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Jun 8, 2017 | A | 1,000 | $0.00 | A | 2,000 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F2 | $111.00 | Jun 8, 2017 | A | 4,000 | A | — | Jun 8, 2027 | Common Stock | 4,000 | 4,000 | D |
Explanation of responses
- F1These restricted stock units for common stock vest 100% on the earlier of June 8, 2018, or the date of the next annual meeting of stockholders.
- F2This option vests 100% on the earlier of June 8, 2018, or the date of the next annual meeting of stockholders.